SCHEMBL8377426

SCHEMBL8377426

CCC([O])c1cccc(C)c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A P08913 4/20 0.39
▸ ADRA2B P18089 4/20 0.39
▸ ADRA2C P18825 4/20 0.39
▸ TSHR P16473 4/20 0.39
▸ ADRA1A P35348 3/20 0.39
▸ ADRA1B P35368 3/20 0.39
▸ ADRA1D P25100 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ SLC6A2 P23975 1/20 0.38
▸ HTR7 P34969 1/20 0.38
▸ TRPA1 O75762 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6221831 0.83 ESR1 (0.46) ADRA2AADRA2BTSHRADRA1AKCNH2
SCHEMBL8380076 0.81 TDP2 (0.31) SMN1; SMN2
SCHEMBL5610783 0.78 ADRA2A (0.41) ADRA2AADRA2BADRA2CTSHRADRA1A
SCHEMBL27391011 0.77 TSHR (0.52) ADRA2AADRA2BADRA2CTSHRADRA1A
SCHEMBL18243012 0.76 CA1 (0.40) TSHRCYP1A2KCNH2CYP3A4CYP2D6
SCHEMBL8036242 0.76 ADRA2A (0.46) ADRA2AADRA2BADRA2CTSHRADRA1A
SCHEMBL375324 0.75 LMNA (0.43) ADRA2AADRA2BADRA2CTSHRADRA1A
SCHEMBL16952697 0.75 TSHR (0.39) ADRA2AADRA2BADRA2CTSHRADRA1A
SCHEMBL30271547 0.75 LMNA (0.43) ADRA2AADRA2BADRA2CTSHRADRA1A
SCHEMBL5147323 0.75 ADRA2A (0.39) ADRA2AADRA2BADRA2CTSHRADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 — — US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 — — EP disclosed
Send feedback